BECLOSPIN 400 micrograms, suspension for inhalation by nebulizer 20 single-dose containers of 1 ml
Active ingredients: DIPROPIONATE DE BÉCLOMÉTASONE
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for inhalation by nebulizer20 single-dose containers of 1 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BECLOSPIN 400 microgrammes, suspension pour inhalation par nébuliseur
- Pharmaceutical form
- suspension pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 20 récipient(s) unidose(s) polypropylène de 1 ml
- Marketing authorisation holder
- CHIESI
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Asthme persistant sévère de l¿enfant (en traitement quotidien). ; JOURNAL OFFICIEL ; 24/11/06
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Nov 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60260910CIP73696344CIP133400936963443Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIPROPIONATE DE BÉCLOMÉTASONEsuspension | 400 microgrammes · 1 ml de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BECLOMETASONE (DIPROPIONATE DE) 400 microgrammes/1 mL - BECLOSPIN 400 microgrammes/1 ml, suspension pour inhalation par nébuliseur